Amalgamated Bank’s Iovance Biotherapeutics IOVA Stock Holding History

Amalgamated Bank’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45K	Buy	+10,798	New	+$41K	﹤0.01%	1624
2026 Q1	–	Sell	-9,661	Closed	-$26K	–	2216
2025 Q4	$26K	Buy	9,661 +151	+2%	+$349	﹤0.01%	2013
2025 Q3	$21K	Hold	9,510	–	–	﹤0.01%	2097
2025 Q2	$16K	Hold	9,510	–	–	﹤0.01%	2204
2025 Q1	$32K	Buy	9,510 +1,179	+14%	+$6.08K	﹤0.01%	1914
2024 Q4	$62K	Hold	8,331	–	–	﹤0.01%	1789
2024 Q3	$78K	Hold	8,331	–	–	﹤0.01%	1747
2024 Q2	$67K	Buy	8,331 +263	+3%	+$2.82K	﹤0.01%	1799
2024 Q1	$120K	Sell	8,068 -12,868	-61%	-$150K	﹤0.01%	1694
2023 Q4	$170K	Sell	20,936 -1,370	-6%	-$7.17K	﹤0.01%	1844
2023 Q3	$101K	Buy	22,306 +4,434	+25%	+$28.9K	﹤0.01%	1993
2023 Q2	$126K	Buy	17,872 +2,321	+15%	+$16.6K	﹤0.01%	1988
2023 Q1	$95K	Sell	15,551 -3,682	-19%	-$25.4K	﹤0.01%	2076
2022 Q4	$123K	Hold	19,233	–	–	﹤0.01%	2051
2022 Q3	$184K	Buy	19,233 +187	+1%	+$2.16K	﹤0.01%	1884
2022 Q2	$210K	Sell	19,046 -9,801	-34%	-$128K	﹤0.01%	1857
2022 Q1	$480K	Buy	28,847 +633	+2%	+$9.79K	﹤0.01%	1560
2021 Q4	$539K	Buy	28,214 +1,514	+6%	+$33.3K	﹤0.01%	1543
2021 Q3	$658K	Sell	26,700 -1,090	-4%	-$25.7K	0.01%	1448
2021 Q2	$723K	Buy	27,790 +2,158	+8%	+$56.1K	0.01%	1445
2021 Q1	$812K	Sell	25,632 -2,234	-8%	-$92.6K	0.03%	698
2020 Q4	$1.29M	Sell	27,866 -6	-0%	-$238	0.05%	400
2020 Q3	$918K	Sell	27,872 -178	-0.6%	-$5.46K	0.04%	489
2020 Q2	$770K	Buy	28,050 +6,950	+33%	+$228K	0.04%	552
2020 Q1	$632K	Sell	21,100 -934	-4%	-$24.8K	0.02%	807
2019 Q4	$610K	Buy	22,034 +1,737	+9%	+$39.5K	0.01%	1021
2019 Q3	$369K	Sell	20,297 -262	-1%	-$5.79K	0.01%	1194
2019 Q2	$504K	Buy	20,559 +5,294	+35%	+$79.7K	0.01%	1070
2019 Q1	$145K	Buy	15,265 +631	+4%	+$6.13K	﹤0.01%	1564
2018 Q4	$130K	Buy	+14,634	New	+$141K	﹤0.01%	1487
2018 Q3	–	Sell	-12,579	Closed	-$161K	–	1532
2018 Q2	$161K	Buy	+12,579	New	+$184K	﹤0.01%	1609

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Amalgamated Bank's IOVA Position: Q2 2026 in Review

Amalgamated Bank opened a new position in Iovance Biotherapeutics (IOVA) in Q2 2026: 10,798 shares worth $45K. The stake represents ﹤0.01% of the portfolio and ranks #1624 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in IOVA as recently as Q4 2025.

Amalgamated Bank first reported a position in IOVA in Q2 2018 and has held it in 31 quarters since. The position peaked at $1.29M in Q4 2020. 120 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Amalgamated Bank held 10,798 shares of Iovance Biotherapeutics worth $45K as of Q2 2026.
Iovance Biotherapeutics was a new Amalgamated Bank position in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1624 holding.
Amalgamated Bank first reported a position in Iovance Biotherapeutics in Q2 2018 and has held it in 31 quarters since.
Amalgamated Bank's Iovance Biotherapeutics position peaked at $1.29M in Q4 2020.
120 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.